9-cis-Retinol Linoleate
![]() |
- $185 - $1455
- Product name: 9-cis-Retinol Linoleate
- CAS: 79299-81-3
- MF: C38H60O2
- MW: 548.88
- EINECS:
- MDL Number:
- Synonyms:9-cis-Retinol Linoleate;9-cis-Retinyl Linoleate;9-cis-retinyl linoleate-d5;Retinol, 9,12-octadecadienoate, [9Z,15(9Z,12Z)]- (9CI);XJKITIOIYQCXQR-WRXPCABDSA-N;Lonafarnib Impurity 4
4 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
- Usbiological
Package
- 1mg
- 10mg
- ManufacturerMedical Isotopes, Inc.
- Product number66945
- Product description9-cis-RetinylLinoleate
- Packaging1mg
- Price$650
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberR275300
- Product description9-cis-RetinylLinoleate
- Packaging1mg
- Price$185
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberR275300
- Product description9-cis-RetinylLinoleate
- Packaging10mg
- Price$1455
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number020601
- Product description9-cis-Retinyl Linoleate
- Packaging1mg
- Price$460
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 66945 | 9-cis-RetinylLinoleate | 1mg | $650 | 2021-12-16 | Buy |
TRC | R275300 | 9-cis-RetinylLinoleate | 1mg | $185 | 2021-12-16 | Buy |
TRC | R275300 | 9-cis-RetinylLinoleate | 10mg | $1455 | 2021-12-16 | Buy |
Usbiological | 020601 | 9-cis-Retinyl Linoleate | 1mg | $460 | 2021-12-16 | Buy |
Properties
Boiling point :631.0±34.0 °C(Predicted)
Density :0.929±0.06 g/cm3(Predicted)
storage temp. :Amber Vial, -86°C Freezer, Under inert atmosphere
solubility :Benzene (Slightly), Ethyl Acetate (Slightly)
form :Oil
color :Pale Yellow
Density :0.929±0.06 g/cm3(Predicted)
storage temp. :Amber Vial, -86°C Freezer, Under inert atmosphere
solubility :Benzene (Slightly), Ethyl Acetate (Slightly)
form :Oil
color :Pale Yellow
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|